Mutational and expressional analyses of PTEN gene in colorectal cancer from Northern India

Molecular Carcinogenesis

Volumn 53, Issue S1, 2014, Pages

  Ali, Asgar ^a   Saluja, Sundeep S ^b   Hajela, Krishnan ^c   Mishra, Pramod K ^b   Rizvi, Moshahid A ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b G B PANT HOSPITAL   (India)

^c DEVI AHILYA UNIVERSITY   (India)

Author keywords

Colorectal cancer; Immunohistochemistry; Mutation; PTEN gene

Indexed keywords

COLORECTAL CANCER; IMMUNOHISTOCHEMISTRY; MUTATION; PTEN GENE;

ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDIA; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; PTEN PHOSPHOHYDROLASE; SURVIVAL RATE;

EID: 84894453233     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22001     Document Type: Article

References (40)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Accessed on 22/04/2012. Available from: http://globocan.iarc.fr
2. Ponz DL, Di Gregorio C. Pathology of colorectal cancer. Dig Liver Dis 2001; 33:372-388.
3. Grady WM, Markowitz SD. Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 2002; 3:101-128.
4. Zheng H, Takahashi H, Murai Y, et al. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: Tissue-array findings. Appl Immunohistochem Mol Morphol 2007; 15:432-440.
5. Fransen K, Klintenas M, Österström A, Dimberg J, Monstein HJ, Söderkvist P. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 2004; 25:527-533.
6. Zheng H, Tsuneyama K, Takahashi H, et al. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas. Anticancer Res 2007; 27:575-581.
7. Yang Y, Shao N, Luo G, Li L, Zheng L, Nilsson-Ehle PXN. Mutations of PTEN gene in gliomas correlate to tumor differentiation and short-term survival rate. Anticancer Res 2010; 30:981-985.
8. Aguissa-Touré AH, Li G. Genetic alterations of PTEN in human melanoma. Cell Mol Life Sci 2012; 69:1475-1491.
9. Gray IC, Phillips SM, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 1995; 55:4800-4803.
10. Suzuki H, Freije D, Nusskern DR, et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 1998; 58:204-209.
11. Kong D, Suzuki A, Zou TT, et al. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 1997; 17:143-144.
12. Risinger JI, Hayes K, Berchuck A, Barrett JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997; 57:4736-4738.
13. Tashiro H, Blazes MS, Wu R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 1997; 57:3935-3940.
14. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 1997; 57:3657-3659.
15. Zhang L, Liu T, Liu H, Gao J, Gu C. Loss and inactivation of PTEN/MMAC1/TEP1 gene in lung cancer. Zhonghua Bing Li Xue Za Zhi 2000; 29:85-88.
16. Mitra AB, Murty VVVS, Li RG, Pratap M, Luthra UK, Chaganti RSK. Allelotype analysis of cervical carcinoma. Cancer Res 1994; 54:4481-4487.
17. Rizvi MA, Alam MS, Mehdi SJ, Ali A, Batra S. Allelic loss at 10q23.3, the PTEN gene locus in cervical carcinoma from northern Indian population. Pathol Oncol Res 2012; 18:309-313.
18. Kurose K, Zhou XP, Araki T, Eng C. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas. Genes Chromosomes Cancer 2000; 29:166-172.
19. Rizvi MA, Shabbir MA, Ali A, Mehdi SJ, Batra S, Mandal AK. Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population. J Cancer Res Clin Oncol 2011; 137:1255-1262.
20. Yang XF, Xin Y, Mao LL. Clinicopathological significance of PTEN and caspase-3 expressions in breast cancer. Chin Med Sci J 2008; 23:95-102.
21. Shin Lee J, Seok Kim H, Bok Kim Y, Cheol Lee M, Soo Park C. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth. J Surg Oncol 2003; 84:166-172.
22. Bowen KA, Doan HQ, Zhou BP, et al. PTEN loss induces epithelial-mesenchymal transition in human colon cancer cells. Anticancer Res 2009; 29:4439-4449.
23. Jang KS, Song YS, Jang SH, et al. Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma. Histopathology 2010; 56:229-239.
24. Naguib A, James CC, Happerfield L, et al. Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: Associations with clinicopathological and dietary factors. BMC Cancer 2011; 11:123.
25. Zhou XP, Loukola A, Salovaara R, et al. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am J Pathol 2002; 161:439-447.
26. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer Sixth Edition Staging. J Natl Cancer Inst 2004; 96:1420-1425.
27. Mehdi SJ, Alam MS, Batra S, Rizvi MMA. Allelic loss at 6q25-27, the Parkin tumor suppressor gene locus in cervical carcinoma. Med Oncol 2011; 28:1520-1526.
28. Sambrook J, Russell DW. Molecular cloning: A laboratory manual. 3rd edition. Cold Spring Harbor: Cold Spring Harbor Lab. Press; 2001.
29. Guo CY, Xu XF, Wu JY, Liu SF. PCR-SSCP-DNA sequencing method in detecting PTEN gene mutation and its significance in human gastric cancer. World J Gastroenterol 2008; 14:3804-3811.
30. Preacher KJ. Calculation for the chi-square test: An interactive calculation tool for chi-square tests of goodness of fit and independence [Computer software]. 2001. Available from http://www.quantpsy.org
31. Samuels Y, Velculescu VE. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 2004; 3:1221-1224.
32. Parsons R. Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol 2004; 15:171-176.
33. Zheng HC, Sun JM, Li XH, Yang XF, Zhang YC, Xin Y. Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma. Pathol Int 2003; 53:659-666.
34. Kim DK, Myung SJ, Yang SK, et al. Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome. Dis Colon Rectum 2005; 48:1714-1722.
35. Wang JY, Huang TJ, Chen FM, et al. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Virchows Arch 2003; 442:437-443.
36. Han SY, Kato H, Kato S, et al. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay. Cancer Res 2000; 60:3147-3151.
37. Tate G, Suzuki T, Mitsuya T. Mutation of the PTEN gene in a human hepatic angiosarcoma. Cancer Genet Cytogenet 2007; 178:160-162.
38. Dicuonzo G, Angeletti S, Garcia-Foncillas J, et al. Colorectal carcinomas and PTEN/MMAC1 gene mutations. Clin Cancer Res 2001; 7:4049-4053.
39. Koul D, Jasser SA, Lu Y, et al. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene 2002; 21:2357-2364.
40. Rizvi MA, Ali A, Mehdi SJ, Saluja SS, Mishra PK. Letter to The Editor: Association of epigenetic alteration in PTEN gene with colorectal cancer progression among Indian population. Int J Colorectal Dis 2012; 1-8. DOI: 10.1007/s00384-012-1482-y.